In this month’s edition of DIFAEM-EPN Minilab Network newsletter, we draw your attention to substandard and falsified medicines, which have recently been identified by the DIFAEM-EPN Minilab Network using the GPHF Minilab.
These products are harmful for patients and must not be used. In case you encounter one of these products, immediately remove it from the shelf and quarantine or destroy it according to the procedures of your
organization/facility.
Please do not return these products to the supplier as in this manner they might be resold to other customers.
In case of question you may contact us using the email addresses below.
Related links
DIFAEM-EPN Minilab network newsletter – May 2023